CN111567797A - Compound jasmine tea chewable tablet and preparation method thereof - Google Patents
Compound jasmine tea chewable tablet and preparation method thereof Download PDFInfo
- Publication number
- CN111567797A CN111567797A CN202010467405.1A CN202010467405A CN111567797A CN 111567797 A CN111567797 A CN 111567797A CN 202010467405 A CN202010467405 A CN 202010467405A CN 111567797 A CN111567797 A CN 111567797A
- Authority
- CN
- China
- Prior art keywords
- jasmine
- parts
- jasmine tea
- extract
- rhizoma polygonati
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000010254 Jasminum officinale Nutrition 0.000 title claims abstract description 146
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 52
- 229940068682 chewable tablet Drugs 0.000 title claims abstract description 43
- 150000001875 compounds Chemical class 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 244000269722 Thea sinensis Species 0.000 title abstract description 93
- 240000005385 Jasminum sambac Species 0.000 title description 2
- 241000207840 Jasminum Species 0.000 claims abstract description 145
- 239000000284 extract Substances 0.000 claims abstract description 68
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 28
- 230000001105 regulatory effect Effects 0.000 claims abstract description 22
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 21
- 239000000796 flavoring agent Substances 0.000 claims abstract description 21
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 18
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 18
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 14
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 57
- 238000007873 sieving Methods 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000000843 powder Substances 0.000 claims description 26
- 238000000605 extraction Methods 0.000 claims description 22
- 238000010298 pulverizing process Methods 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 16
- 235000000346 sugar Nutrition 0.000 claims description 16
- 238000000926 separation method Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 239000003826 tablet Substances 0.000 claims description 14
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 13
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 13
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 13
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 13
- 239000007779 soft material Substances 0.000 claims description 13
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 10
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 7
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 7
- 239000008347 soybean phospholipid Substances 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 241000037831 Polygonatum sibiricum Species 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000000643 oven drying Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 238000002137 ultrasound extraction Methods 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000000469 ethanolic extract Substances 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 2
- 241001122767 Theaceae Species 0.000 claims 14
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 18
- 230000001603 reducing effect Effects 0.000 abstract description 14
- 230000032683 aging Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 7
- 230000003647 oxidation Effects 0.000 abstract description 7
- 238000007254 oxidation reaction Methods 0.000 abstract description 7
- 235000019640 taste Nutrition 0.000 abstract description 7
- 210000005036 nerve Anatomy 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- 210000002216 heart Anatomy 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 80
- 239000000306 component Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 150000004676 glycans Chemical class 0.000 description 11
- 229920001282 polysaccharide Polymers 0.000 description 11
- 239000005017 polysaccharide Substances 0.000 description 11
- 229930006000 Sucrose Natural products 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 235000009569 green tea Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000220317 Rosa Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229940109850 royal jelly Drugs 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 241000205585 Aquilegia canadensis Species 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000756042 Polygonatum Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000005856 steroid saponins Chemical class 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- BTJXBZZBBNNTOV-UHFFFAOYSA-N Linalyl benzoate Chemical compound CC(C)=CCCC(C)(C=C)OC(=O)C1=CC=CC=C1 BTJXBZZBBNNTOV-UHFFFAOYSA-N 0.000 description 2
- 241001468611 Polygonatum cyrtonema Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 235000007457 Jasminum sambac Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound jasmine tea chewable tablet and a preparation method thereof, wherein the compound jasmine tea chewable tablet is prepared from the following raw materials in parts by weight: 20-40 parts of jasmine tea, 15-25 parts of jasmine extract, 5-15 parts of rhizoma polygonati extract, 10-20 parts of dendrobium officinale, 5-15 parts of soybean lecithin, 10-30 parts of excipient, 0.5-2 parts of magnesium stearate and 5-10 parts of flavoring agent. The compound jasmine tea chewable tablet can be directly chewed to be convenient for digestion and absorption, has good taste and good flavor, can provide various nutritional ingredients and medicinal active ingredients for a human body, and has the effects of regulating qi, soothing the nerves, reducing blood pressure and blood fat, protecting heart and cerebral vessels, resisting aging and oxidation, and improving immunity and memory. The preparation method of the compound jasmine tea chewable tablet is simple and can be used for industrial production; the compound jasmine tea chewable tablet prepared by the method develops new applications of jasmine and jasmine tea, and has good economic benefit.
Description
Technical Field
The invention belongs to the technical field of health-care food, and relates to a compound jasmine tea chewable tablet and a preparation method thereof.
Background
Jasmine, namely the alias: jasmine, Latin name:Jasminum sambac (L.) Aitthe jasmine is extremely fragrant, and is a famous scented tea raw material and an important essence raw material. The jasmine flower can be used for extracting jasmine flower oil, and the oil mainly contains benzyl alcohol and its esters, jasminoidin, linalool, and linalyl benzoate. Jasmine is cold in nature and has the effects of clearing liver and improving vision, relaxing bowels and promoting diuresis, reducing blood pressure, regulating qi and calming nerves. Modern medical research shows that the components contained in the jasmine flower have a plurality of pharmacological effects: tranquilizing, antibacterial, antioxidant, improving diabetes, preventing and treating depression, relieving gastrointestinal discomfort, caring oral cavity, promoting health of cardiovascular and cerebrovascular system, and enhancing immunity. The jasmine tea is prepared by blending and scenting tea and fresh jasmine flower to make tea absorb fragrance; it has lasting fragrance, mellow taste, bright yellow green color, and tender and soft leaf bottom. The jasmine tea scented by a series of technological processes has the effects of soothing the nerves, relieving depression, strengthening the spleen, regulating qi, resisting aging and improving the immunity of the organism, and is a healthy drink.
The chewable tablet is a tablet which is chewed in the oral cavity and then swallowed, and is easy to be accepted by patients due to good taste and convenient taking. Chewable tablets, as a pharmaceutical dosage form, have advantages over other dosage forms: the disintegration time is short, the dispersion state is good, and the medicine is quickly dissolved out; the composition has the advantages of high absorption speed, high bioavailability, convenient administration, no time and place limitation, chewing, swallowing, sucking or water dispersion, and further reduced irritation of the medicine to gastrointestinal tract. The preparation is especially suitable for the elderly, children and dysphagia patients. In addition, some bitter tablets are coated to cover the bitter taste, so that the yield is low, and the coating process can be omitted after the tablets are prepared into chewable tablets, so that the production period is shortened, and the yield is improved.
The patent application CN109793066A aims at the product blank of green tea and honeysuckle chewable tablets in the market, the green tea powder and honeysuckle powder are processed by adopting a vacuum freeze-drying method, then microcrystalline cellulose, mannitol, magnesium stearate, Arabic gum, acesulfame potassium, aspartame and the like are added to prepare the green tea chewable tablets, so that the components of green tea, such as tea polyphenol, caffeine, vitamins and honeysuckle for resisting inflammation and diminishing swelling are effectively reserved, and the green tea chewable tablets have the effects of sterilizing the oral cavity, diminishing inflammation, strengthening teeth and refreshing breath. Patent application CN105767297A discloses a rose tea chewable tablet and a preparation method thereof, wherein hot air dried rose produced in the same year and tea are taken as main raw materials, and the rose tea chewable tablet is prepared from the following raw materials in percentage by weight: 25-45% of rose pollen, 25-45% of tea powder, 5-10% of cyclodextrin, 5-15% of starch, 1-3% of sucrose, 0.2-1.5% of sodium citrate, 0.2-1.5% of malic acid and 1-3% of magnesium stearate, and the obtained chewable tablets well retain the special fragrance of rose and tea, are cool in mouth and convenient to use; the chewable tablet is compact and uniform in tabletting, neat in appearance and smooth and clean in surface; the invention has the advantages of easily obtained raw materials, simple process and easy production. Patent application CN102106497A discloses a preparation method of compound combined rape pollen chewable tablets: firstly, crushing 15-60 parts of rape pollen by a crusher, sieving by a sieve of 80-200 meshes, respectively crushing 5-20 parts of soybean lecithin, 1-10 parts of angelica extract, 0.1-5 parts of royal jelly freeze-dried powder, 0.01-2 parts of tea polyphenol and 0.1-5 parts of vitamin, and sieving by a sieve of 40-60 meshes; 3-40 parts of excipient soft sugar and microcrystalline cellulose are crushed and sieved by a 100-mesh sieve; mixing the pulverized raw materials, excipient soft sugar and microcrystalline cellulose, and flavoring agent soft sugar 0.1-20 parts, making into soft material, granulating, oven drying at 35-65 deg.C, granulating, mixing with lubricant magnesium stearate 0.1-10 parts, tabletting to obtain various tablets of different types, and moisture-proof packaging. The prepared compound combined rape pollen chewable tablet integrates the advantages of rape pollen, soybean lecithin, royal jelly freeze-dried powder, angelica and the like, is prepared by adopting modern food processing technology, has good taste and mouthfeel, is easy to store, convenient to carry and take, is rich in various nutrient substances, and has the functions of resisting oxidation and aging, benefiting intestines and stomach, maintaining beauty and keeping young, eliminating brain fatigue, enhancing intelligence quotient, improving human memory and the like. The invention not only retains the nutritive value of rape pollen, but also highlights a plurality of physiological regulation functions of the soybean lecithin and the royal jelly freeze-dried powder, thereby playing a strong and obvious synergistic effect and greatly increasing the overall efficacy of the soybean lecithin and royal jelly freeze-dried powder.
Guangxi Zhuang autonomous region Nanning City Yong Xian is the global jasmine peanut production center, and the yield and quality of jasmine flower are the first of China. The prior jasmine is generally used for making sachets and pillows, scenting tea, making beverages, extracting jasmine essential oil and the like, and is mainly used for producing jasmine tea, and with the revolution of times, the continuous increase of the yield and the cost of the jasmine and the aggravation of market competition, the deep processing into products with high added value is a necessary way for the later development of the jasmine and jasmine tea industry. At present, a small number of people and enterprises extract and purify the effective components of jasmine flowers and jasmine tea in a modern way, and then further process the effective components into products with higher added values such as food, medicines, cosmetics and health care products, but no report on chewable tablets of jasmine tea exists so far.
Disclosure of Invention
The invention aims to provide a compound jasmine tea chewable tablet and a preparation method thereof, the compound jasmine tea chewable tablet can be directly chewed to be convenient for digestion and absorption, has good taste and good flavor, can provide a plurality of nutrient components and medicinal active components for a human body, and has the effects of regulating qi, soothing nerves, reducing blood pressure and blood fat, protecting cardiovascular and cerebrovascular systems, resisting aging and oxidation, and improving immunity and memory. The preparation method of the compound jasmine tea chewable tablet is simple and can be used for industrial production; the compound jasmine tea chewable tablet prepared by the method develops new applications of jasmine and jasmine tea, and has good economic benefit.
The technical scheme of the invention is as follows:
the compound jasmine tea chewable tablet is prepared from the following raw materials in parts by weight: 20-40 parts of jasmine tea, 15-25 parts of jasmine extract, 5-15 parts of rhizoma polygonati extract, 10-20 parts of dendrobium officinale, 5-15 parts of soybean lecithin, 10-30 parts of excipient, 0.5-2 parts of magnesium stearate and 5-10 parts of flavoring agent.
The jasmine tea is preferably a tender tea with one bud and one leaf or two leaves scented by jasmine produced in the county of Guangxi Nanning City.
The excipient is a mixture of soft white sugar and microcrystalline cellulose, and the weight ratio of the soft white sugar to the microcrystalline cellulose is 1: 2-3.
The flavoring agent is one or more selected from fructo-oligosaccharide, isomaltooligosaccharide, xylitol, and Mel.
The preparation method of the compound jasmine tea chewable tablet comprises the following steps:
(1) firstly, crushing jasmine tea by using a crusher, and then sieving the crushed jasmine tea by using a 100-sand 200-mesh sieve; removing leaves of fresh Dendrobium officinale, cleaning, cutting into 2-4cm segments, air drying, pulverizing with ultramicro pulverizer, and sieving with 500 mesh sieve.
(2) Pulverizing flos Jasmini sambac extract, rhizoma Polygonati extract, and soybean phospholipid, sieving with 40-60 mesh sieve, pulverizing excipient, and sieving with 100 mesh sieve.
(3) And (3) uniformly mixing the crushed and sieved raw materials with a flavoring agent according to the weight part to prepare a soft material.
(4) Extruding the obtained soft material, sieving with 20 mesh sieve, dispersing into uniform wet granules with less fine powder, oven drying at 40-50 deg.C until the water content of the material is below 3%, grading, making into uniform granules, sieving with 20 mesh sieve, mixing with magnesium stearate, tabletting with tablet press to obtain various tablets with different types, and moisture-proof packaging.
The jasmine flower extract is prepared from CO2The jasmine flower cephalanoplos extract is obtained by extracting with a supercritical extraction device through the following steps:
(1) selecting fresh jasmine picked in the same day, and soaking and washing with deionized water for 10-30 min;
(2) loading the washed fresh jasmine into an extraction kettle;
(3) the temperature of the extraction kettle is regulated to be 308-318K, the pressure is regulated to be 12-15MPa, and the temperature of the separation kettle is regulated to be 308-318K; turn on CO2CO of supercritical extraction device2A gas cylinder, and pressurizing;
(4) when the pressure is increased to jasmine flower and CO2Standing for 30-90min after forming mixed fluid;
(5) CO regulation2The flow rate is 1-4L/h, and dynamic extraction is started; after 60-120min, finishing extraction, opening the device to discharge to obtain the jasmine flower cephalanoplos extract.
The preparation method of the polygonatum sibiricum extract comprises the following steps:
(1) pulverizing dried rhizoma Polygonati slice, sieving with 40 mesh sieve to obtain rhizoma Polygonati powder, placing rhizoma Polygonati powder into ultrahigh pressure equipment, adding 15-20 times of water, and maintaining the pressure at 245-; then carrying out solid-liquid separation to obtain the rhizoma polygonati water extract.
(2) Adding the filter residue obtained in the step (1) into 65-75% ethanol solution with a material-liquid ratio of filter residue to ethanol solution of 1:12-18, performing ultrasonic extraction in 50-60 deg.C water bath for 10-20min, and performing solid-liquid separation to obtain rhizoma Polygonati ethanol extract.
(3) Mixing the above rhizoma Polygonati water extractive solution and rhizoma Polygonati ethanol extractive solution, and concentrating under reduced pressure at 45-50 deg.C to dry to obtain rhizoma Polygonati extract.
Some of the raw materials used in the present invention are as follows:
rhizoma Polygonati (polygonatum) Is prepared from (A) of LiliaceaeLiliaceaea) Sealwort belongs toPolygonatum) Polygonatum kingianum (rhizoma polygonati) of perennial herbPolygonatum kingianum Coll.et Hemsl) Rhizoma Polygonati (1)Polygonatum sibiricum Red.) Or Polygonatum cyrtonema Hua (C)Polygonatumcyrtonema Hua) The modern research shows that: rhizoma Polygonati mainly contains various functional components such as polysaccharide, steroid saponins, anthraquinone, alkaloid and amino acids, and has effects of resisting oxidation, resisting inflammation, reducing blood lipid, preventing arteriosclerosis, lowering blood sugar, improving memory, resisting tumor, regulating immunity and resisting virus. The polysaccharide is one of the main active ingredients of rhizoma polygonati. Modern medical research shows that: rhizoma Polygonati polysaccharide has effects of lowering blood sugar, inhibiting osteoporosis, prolonging animal life, resisting aging, resisting inflammation and virus, and protecting against chemical hepatic injury; the rhizoma Polygonati polysaccharide can improve brain function to achieve the purpose of delaying aging and enhancing brain learning and memory functions. Rhizoma Polygonati and its extract can be used for resisting apoptosis, resisting oxidation free radical, and regulating nerve transmissionThe quality of the blood is regulated and protected, so that the neurovascular unit is improved.
Dendrobium officinale (academic name:Dendrobium officinale Kimura et Migo) The dendrobium nobile lindl is a perennial epiphytic herb plant of the dendrobium of the orchidaceae, is famous because the epidermis is iron green, has unique medicinal value, is listed as the head of the jiudao sianchau in China, is listed as the top-grade traditional Chinese medicine together with lucid ganoderma, ginseng, cordyceps sinensis and the like, is a traditional famous and precious Chinese herbal medicine, and is vegetatively reputed by gold in medicine, Chinese immortal grass and the like. The dendrobium officinale stems are used as medicines, belong to yin-tonifying medicines in tonifying medicines, and have the effects of tonifying stomach, promoting the production of body fluid, nourishing yin, clearing heat, enhancing the immunity of the organism, resisting fatigue, promoting gastric secretion, aiding digestion, protecting liver, benefiting gallbladder, reducing blood sugar, resisting tumors and the like.
Soybean phospholipids are products extracted from oil bottoms from the production of soybean oil, and are esters composed of glycerol, fatty acids, choline or cholestyramine. The soybean lecithin contains various active substances such as organic phosphorus, choline and inositol, also contains essential fatty acid required by human body, does not contain cholesterol, and is a guarantee for metabolism and healthy survival of human body. The soybean lecithin has the functions of resisting oxidation, resisting aging, reducing blood fat, promoting blood circulation, maintaining beauty and keeping young, eliminating brain fatigue, improving memory and the like.
The invention has the following beneficial effects:
the jasmine tea chewable tablet contains a plurality of active ingredients including jasmine tea, jasmine extract, sealwort extract, dendrobium officinale and soybean lecithin. The jasmine tea is a green tea obtained by scenting jasmine and tea, preferably a tender tea with one bud and one leaf or two leaves scented by the jasmine produced in the horizontal county of southern Guangxi, the jasmine in the horizontal county has strong fragrance, the obtained jasmine tea has good quality and lasting fragrance, and the jasmine tea is directly taken as a medicine in micro powder, so the tender tea has good taste and is more acceptable by people. The jasmine tea is prepared from micro powder, and active ingredients and nutritional ingredients contained in the tea, such as tea polyphenol, tea polysaccharide, caffeine, vitamins and the like, can be well retained. Tea polyphenol in tea is a natural antioxidant, has the effects of inhibiting virus activity, resisting bacteria, resisting mutagenesis, treating neurodegenerative diseases, resisting cancer and the like, and has the effects of trapping free radicals in organisms, resisting aging, resisting radiation, losing weight, reducing blood fat, preventing cancer and the like. In addition, it has good preventing and treating effects on diseases of immune system, especially AIDS. Modern medical research shows that tea polysaccharide is one of main pharmacological components of tea for treating diabetes, and the tea polysaccharide mainly comprises glucose, arabinose, xylose, fucose, ribose, galactose and the like. The tea polysaccharide has effects of preventing and treating diabetes by lowering blood sugar and blood lipid; meanwhile, the anticoagulant, antithrombotic, blood phase protection and human nonspecific immunity enhancement have obvious effects.
Modern medical research shows that the components contained in the jasmine flower have a plurality of pharmacological effects: tranquilizing, antibacterial, antioxidant, improving diabetes, preventing and treating depression, relieving gastrointestinal discomfort, caring oral cavity, promoting health of cardiovascular and cerebrovascular system, and enhancing immunity. The jasmine tea integrates the effects of tea and jasmine, and the jasmine extract is additionally added in the chewable tablet, so that the jasmine fragrance of the chewable tablet is enhanced, the flavor of jasmine essential oil is blended, and the chewable tablet emits heavy jasmine fragrance from inside to outside and tastes sweet and mellow. The jasmine flower extract of the invention adopts CO2Extracting with supercritical extraction device to obtain flos Jasmini sambac extract, and extracting with CO2The supercritical extraction method is used for extracting the jasmine, the yield of the jasmine extract is up to more than 0.38%, and the jasmine essential oil in the obtained jasmine extract has high purity and strong fragrance.
Modern medical research shows that tea polysaccharide, dendrobium officinale and sealwort can inhibit the activity of alpha-glucosidase, and the three medicines are combined to play a synergistic role, so that a better blood sugar reducing effect is achieved. The polygonatum extract and the dendrobium officinale have the effects of reducing blood sugar and resisting tumors, and the polygonatum extract and the dendrobium officinale powder are added into the jasmine tea chewable tablets, so that the blood sugar reducing effect of the tea can be effectively enhanced. Pulverizing rhizoma Polygonati, performing water extraction under ultrahigh pressure to obtain rhizoma Polygonati water extractive solution, extracting rhizoma Polygonati polysaccharide with extraction rate of 20-25%, performing ultrasonic extraction of the residue after water extraction under ultrahigh pressure with 65-75% ethanol solution to obtain rhizoma Polygonati ethanol extractive solution containing flavonoids and steroid saponins, mixing rhizoma Polygonati water extractive solution and rhizoma Polygonati ethanol extractive solution, and concentrating to dry to obtain rhizoma Polygonati extract with high content of active components rhizoma Polygonati polysaccharide, flavonoids and steroid saponins and high drug effect. Beneficial flora in human body mainly comprises lactobacillus and bifidobacterium, the dendrobium officinale ultra-fine powder with more than 500 meshes can promote the proliferation of the lactobacillus and the bifidobacterium, and the dendrobium officinale can be used as a raw material of a chewable tablet after being sieved by a sieve with 500 meshes, so that the proliferation of beneficial bacteria in intestinal tract can be promoted.
The soybean phospholipid has antioxidant, antiaging and blood lipid reducing effects, and can be added into chewable tablet of jasmine tea to enhance antioxidant, antiaging and blood lipid reducing effects of tea polyphenols. In the chewable tablet, jasmine tea, jasmine extract, sealwort extract, dendrobium officinale and soybean lecithin play a synergistic role in reducing blood sugar, blood fat, tumors, oxidation and aging, refreshing mind, relieving fatigue, maintaining beauty, keeping young, improving memory and the like, and have excellent health-care effect.
When the flavoring agent is selected, one or more of fructo-oligosaccharide, isomaltose hypgather, xylitol and honey are selected, and the whole blood sugar reducing effect is not influenced by low sugar content. The fructo-oligosaccharide or isomalto-oligosaccharide can promote the beneficial bacteria in human body, namely bifidobacterium to obviously proliferate, has the efficacy of water-soluble dietary fiber, can prevent dental caries, is widely applied functional oligosaccharide, and is also a product for nourishing intestines and protecting health; because the sugar-free sweetener does not contain glucose, the sweetener is also a common sweetener in foods for diabetics. Xylitol does not need insulin to participate in the metabolism in vivo, does not increase the blood sugar value, and can eliminate more than three (polydipsia, polyuria and polyphagia) of diabetics, so that the xylitol is a safe sweetening agent, a nutritional supplement and an auxiliary therapeutic agent for the diabetics. The honey can improve blood components and promote functions of heart, brain and blood vessels; has protective effect on liver, can promote liver cell regeneration, and has certain inhibiting effect on fatty liver; and has effects of killing bacteria, promoting gastrointestinal peristalsis, relieving fatigue, and enhancing resistance.
In the preparation process of the chewable tablet, the jasmine extract and the sealwort extract are extracted and prepared, then the raw material components are crushed to proper sizes and mixed uniformly to prepare soft materials, and then the soft materials are granulated, granulated and finally mixed with the lubricant uniformly to be tabletted, so that the chewable tablet is prepared, and the preparation method is simple and can be used for industrial production. The compound jasmine tea chewable tablet prepared by the method develops new applications of jasmine and jasmine tea, and has good economic benefit.
Detailed Description
In order to describe the present invention in more detail, the present invention will be further described with reference to the following examples.
Example 1
The compound jasmine tea chewable tablet is prepared from the following raw materials in parts by weight: 20 parts of jasmine tea, 15 parts of jasmine extract, 5 parts of rhizoma polygonati extract, 10 parts of dendrobium officinale, 5 parts of soybean lecithin, 10 parts of excipient, 0.5 part of magnesium stearate and 5 parts of flavoring agent.
The jasmine tea is prepared from tender tea with one bud and one leaf or two leaves scented by jasmine produced in Yongxi Nanning City and Yongxian county.
The excipient is a mixture of soft white sugar and microcrystalline cellulose, and the weight ratio of the soft white sugar to the microcrystalline cellulose is 1: 3.
The flavoring agent is one or more selected from fructo-oligosaccharide, isomaltooligosaccharide, xylitol, and Mel.
The preparation method of the compound jasmine tea chewable tablet comprises the following steps:
(1) firstly, crushing jasmine tea by using a crusher, and then sieving the crushed jasmine tea by using a 100-mesh sieve; removing leaves of fresh Dendrobium officinale, cleaning, cutting into 2-4cm segments, air drying, pulverizing with ultramicro pulverizer, and sieving with 500 mesh sieve.
(2) Respectively pulverizing flos Jasmini sambac extract, rhizoma Polygonati extract, and soybean phospholipid, sieving with 40 mesh sieve, pulverizing excipient, and sieving with 100 mesh sieve.
(3) The crushed and sieved raw materials are uniformly mixed with a flavoring agent according to the weight part to prepare a soft material in a state of being held by hand to form a mass and being dispersed by light pressure.
(4) Extruding the obtained soft material, sieving with 20 mesh sieve, dispersing into uniform wet granules with less fine powder, oven drying at 40-50 deg.C until the water content of the material is below 3%, grading, making into uniform granules, sieving with 20 mesh sieve, mixing with magnesium stearate, tabletting with tablet press to obtain various tablets with different types, and moisture-proof packaging.
The jasmine flower extract is prepared from CO2The jasmine flower cephalanoplos extract is obtained by extracting with a supercritical extraction device through the following steps:
(1) selecting fresh jasmine picked in the same day, and soaking and washing with deionized water for 10 min;
(2) loading the washed fresh jasmine into an extraction kettle;
(3) the temperature of the extraction kettle is regulated to be 308-318K, the pressure is regulated to be 12-15MPa, and the temperature of the separation kettle is regulated to be 308-318K; turn on CO2CO of supercritical extraction device2A gas cylinder, and pressurizing;
(4) when the pressure is increased to jasmine flower and CO2Standing for 30min after forming mixed fluid;
(5) CO regulation2The flow rate is 4L/h, and dynamic extraction is started; after 60min, finishing extraction, opening the device and discharging to obtain the jasmine flower cephalanoplos extract.
The preparation method of the polygonatum sibiricum extract comprises the following steps:
(1) pulverizing dried rhizoma Polygonati slice, sieving with 40 mesh sieve to obtain rhizoma Polygonati powder, placing rhizoma Polygonati powder into ultrahigh pressure equipment, adding 15 times of water, and maintaining pressure at 245-; then carrying out solid-liquid separation to obtain the rhizoma polygonati water extract.
(2) Adding the filter residue obtained in the step (1) into 75% ethanol solution with the material-liquid ratio of the filter residue to the ethanol solution being 1:12, placing the filter residue and the ethanol solution in a water bath at 50-60 ℃, performing ultrasonic extraction for 10min, and performing solid-liquid separation to obtain rhizoma polygonati ethanol extract.
(3) Mixing the above rhizoma Polygonati water extractive solution and rhizoma Polygonati ethanol extractive solution, and concentrating under reduced pressure at 45-50 deg.C to dry to obtain rhizoma Polygonati extract.
Example 2
The compound jasmine tea chewable tablet is prepared from the following raw materials in parts by weight: 30 parts of jasmine tea, 20 parts of jasmine extract, 10 parts of rhizoma polygonati extract, 15 parts of dendrobium officinale, 10 parts of soybean lecithin, 20 parts of excipient, 1.2 parts of magnesium stearate and 8 parts of flavoring agent.
The jasmine tea is prepared from tender tea with one bud and one leaf or two leaves scented by jasmine produced in Yongxi Nanning City and Yongxian county.
The excipient is a mixture of soft white sugar and microcrystalline cellulose, and the weight ratio of the soft white sugar to the microcrystalline cellulose is 1: 3.
The flavoring agent is one or more selected from fructo-oligosaccharide, isomaltooligosaccharide, xylitol, and Mel.
The preparation method of the compound jasmine tea chewable tablet comprises the following steps:
(1) firstly, crushing jasmine tea by using a crusher, and then sieving the crushed jasmine tea by using a 150-mesh sieve; removing leaves of fresh Dendrobium officinale, cleaning, cutting into 2-4cm segments, air drying, pulverizing with ultramicro pulverizer, and sieving with 500 mesh sieve.
(2) Respectively pulverizing flos Jasmini sambac extract, rhizoma Polygonati extract, and soybean phospholipid, sieving with 50 mesh sieve, pulverizing excipient, and sieving with 100 mesh sieve.
(3) The crushed and sieved raw materials are uniformly mixed with a flavoring agent according to the weight part to prepare a soft material in a state of being held by hand to form a mass and being dispersed by light pressure.
(4) Extruding the obtained soft material, sieving with 20 mesh sieve, dispersing into uniform wet granules with less fine powder, oven drying at 40-50 deg.C until the water content of the material is below 3%, grading, making into uniform granules, sieving with 20 mesh sieve, mixing with magnesium stearate, tabletting with tablet press to obtain various tablets with different types, and moisture-proof packaging.
The jasmine flower extract is prepared from CO2The jasmine flower cephalanoplos extract is obtained by extracting with a supercritical extraction device through the following steps:
(1) selecting fresh jasmine picked in the same day, and soaking and washing with deionized water for 20 min;
(2) loading the washed fresh jasmine into an extraction kettle;
(3) the temperature of the extraction kettle is regulated to be 308-318K, the pressure is regulated to be 12-15MPa, and the temperature of the separation kettle is regulated to be 308-318K; turn on CO2CO of supercritical extraction device2A gas cylinder, and pressurizing;
(4) when the pressure is increased to jasmine flower and CO2Standing for 60min after forming mixed fluid;
(5) CO regulation2The flow rate is 3L/h, and dynamic extraction is started; after 90min, finishing extraction, opening the device and discharging to obtain the jasmine flower cephalanoplos extract.
The preparation method of the polygonatum sibiricum extract comprises the following steps:
(1) crushing the dried rhizoma polygonati slices, sieving the crushed rhizoma polygonati slices with a 40-mesh sieve to obtain rhizoma polygonati powder, putting the rhizoma polygonati powder into ultrahigh pressure equipment, adding 18 times of water by weight, and maintaining the pressure for 10min under the condition that the pressure is 245-; then carrying out solid-liquid separation to obtain the rhizoma polygonati water extract.
(2) Adding the filter residue obtained in the step (1) into an ethanol solution with the volume concentration of 70%, wherein the material-liquid ratio of the filter residue to the ethanol solution is 1:15, placing the filter residue and the ethanol solution in a water bath at 50-60 ℃, performing ultrasonic extraction for 15min, and performing solid-liquid separation to obtain an ethanol extract of rhizoma polygonati.
(3) Mixing the above rhizoma Polygonati water extractive solution and rhizoma Polygonati ethanol extractive solution, and concentrating under reduced pressure at 45-50 deg.C to dry to obtain rhizoma Polygonati extract.
Example 3
The compound jasmine tea chewable tablet is prepared from the following raw materials in parts by weight: 40 parts of jasmine tea, 25 parts of jasmine extract, 15 parts of rhizoma polygonati extract, 20 parts of dendrobium officinale, 15 parts of soybean lecithin, 30 parts of excipient, 2 parts of magnesium stearate and 10 parts of flavoring agent.
The jasmine tea is prepared from tender tea with one bud and one leaf or two leaves scented by jasmine produced in Yongxi Nanning City and Yongxian county.
The excipient is a mixture of soft white sugar and microcrystalline cellulose, and the weight ratio of the soft white sugar to the microcrystalline cellulose is 1: 2.
The flavoring agent is one or more selected from fructo-oligosaccharide, isomaltooligosaccharide, xylitol, and Mel.
The preparation method of the compound jasmine tea chewable tablet comprises the following steps:
(1) firstly, crushing jasmine tea by using a crusher, and then sieving the crushed jasmine tea by using a 200-mesh sieve; removing leaves of fresh Dendrobium officinale, cleaning, cutting into 2-4cm segments, air drying, pulverizing with ultramicro pulverizer, and sieving with 500 mesh sieve.
(2) Respectively pulverizing flos Jasmini sambac extract, rhizoma Polygonati extract, and soybean phospholipid, sieving with 60 mesh sieve, pulverizing excipient, and sieving with 100 mesh sieve.
(3) The crushed and sieved raw materials are uniformly mixed with a flavoring agent according to the weight part to prepare a soft material in a state of being held by hand to form a mass and being dispersed by light pressure.
(4) Extruding the obtained soft material, sieving with 20 mesh sieve, dispersing into uniform wet granules with less fine powder, oven drying at 40-50 deg.C until the water content of the material is below 3%, grading, making into uniform granules, sieving with 20 mesh sieve, mixing with magnesium stearate, tabletting with tablet press to obtain various tablets with different types, and moisture-proof packaging.
The jasmine flower extract is prepared from CO2The jasmine flower cephalanoplos extract is obtained by extracting with a supercritical extraction device through the following steps:
(1) selecting fresh jasmine picked in the same day, and soaking and washing with deionized water for 30 min;
(2) loading the washed fresh jasmine into an extraction kettle;
(3) the temperature of the extraction kettle is regulated to be 308-318K, the pressure is regulated to be 12-15MPa, and the temperature of the separation kettle is regulated to be 308-318K; turn on CO2CO of supercritical extraction device2A gas cylinder, and pressurizing;
(4) when the pressure is increased to jasmine flower and CO2Standing for 90min after forming mixed fluid;
(5) CO regulation2The flow rate is 1L/h, and dynamic extraction is started; after 120min, finishing extraction, opening the device and discharging to obtain the jasmine flower top note extract.
The preparation method of the polygonatum sibiricum extract comprises the following steps:
(1) pulverizing dried rhizoma Polygonati slice, sieving with 40 mesh sieve to obtain rhizoma Polygonati powder, placing rhizoma Polygonati powder into ultrahigh pressure equipment, adding 20 times of water, and maintaining the pressure at 245-; then carrying out solid-liquid separation to obtain the rhizoma polygonati water extract.
(2) Adding the filter residue obtained in the step (1) into 65% ethanol solution with the volume concentration of 1:18, placing the filter residue and the ethanol solution in a water bath at 50-60 ℃, performing ultrasonic extraction for 20min, and performing solid-liquid separation to obtain rhizoma polygonati ethanol extract.
(3) Mixing the above rhizoma Polygonati water extractive solution and rhizoma Polygonati ethanol extractive solution, and concentrating under reduced pressure at 45-50 deg.C to dry to obtain rhizoma Polygonati extract.
Claims (7)
1. The compound jasmine tea chewable tablet is characterized by being prepared from the following raw materials in parts by weight: 20-40 parts of jasmine tea, 15-25 parts of jasmine extract, 5-15 parts of rhizoma polygonati extract, 10-20 parts of dendrobium officinale, 5-15 parts of soybean lecithin, 10-30 parts of excipient, 0.5-2 parts of magnesium stearate and 5-10 parts of flavoring agent.
2. The compound jasmine tea chewable tablet of claim 1, wherein the jasmine tea is a tender tea with one or two leaves in one bud scented from jasmine produced in the county of southern Guangxi.
3. The compound jasmine tea chewable tablet of claim 1, wherein the excipient is a mixture of soft sugar and microcrystalline cellulose, and the weight ratio of the soft sugar to the microcrystalline cellulose is 1: 2-3.
4. The compound jasmine tea chewable tablet of claim 1, wherein the flavoring agent is one or more of fructo-oligosaccharide, isomalto-oligosaccharide, xylitol and honey.
5. The compound jasmine tea chewable tablet of claim 1, wherein the jasmine is a jasmine tea chewable tabletThe flower extract is prepared from CO2The jasmine flower cephalanoplos extract obtained by the supercritical extraction device comprises the following specific extraction steps:
(1) selecting fresh jasmine picked in the same day, and soaking and washing with deionized water for 10-30 min;
(2) loading the washed fresh jasmine into an extraction kettle;
(3) the temperature of the extraction kettle is regulated to be 308-318K, the pressure is regulated to be 12-15MPa, and the temperature of the separation kettle is regulated to be 308-318K; turn on CO2CO of supercritical extraction device2A gas cylinder, and pressurizing;
(4) when the pressure is increased to jasmine flower and CO2Standing for 30-90min after forming mixed fluid;
(5) CO regulation2The flow rate is 1-4L/h, and dynamic extraction is started; after 60-120min, finishing extraction, opening the device to discharge to obtain the jasmine flower cephalanoplos extract.
6. The compound jasmine tea chewable tablet of claim 1, wherein the preparation method of the polygonatum sibiricum extract comprises the following steps:
(1) pulverizing dried rhizoma Polygonati slice, sieving with 40 mesh sieve to obtain rhizoma Polygonati powder, placing rhizoma Polygonati powder into ultrahigh pressure equipment, adding 15-20 times of water, and maintaining the pressure at 245-; then carrying out solid-liquid separation to obtain a rhizoma polygonati water extracting solution;
(2) adding the filter residue obtained in the step (1) into 65-75% ethanol solution with a material-liquid ratio of filter residue to ethanol solution of 1:12-18, performing ultrasonic extraction in 50-60 deg.C water bath for 10-20min, and performing solid-liquid separation to obtain rhizoma Polygonati ethanol extract;
(3) mixing the above rhizoma Polygonati water extractive solution and rhizoma Polygonati ethanol extractive solution, and concentrating under reduced pressure at 45-50 deg.C to dry to obtain rhizoma Polygonati extract.
7. The compound jasmine tea chewable tablet of claim 1, wherein the preparation method of the compound jasmine tea chewable tablet comprises the following steps:
(1) firstly, crushing jasmine tea by using a crusher, and then sieving the crushed jasmine tea by using a 100-sand 200-mesh sieve; removing leaves of fresh Dendrobium officinale, cleaning, cutting into 2-4cm segments, air drying, pulverizing with an ultrafine pulverizer, and sieving with 500 mesh sieve;
(2) respectively pulverizing flos Jasmini sambac extract, rhizoma Polygonati extract, and soybean phospholipid, sieving with 40-60 mesh sieve, pulverizing excipient, and sieving with 100 mesh sieve;
(3) mixing the crushed and sieved raw materials with a flavoring agent uniformly according to the weight part to prepare a soft material;
(4) extruding the obtained soft material, sieving with 20 mesh sieve, dispersing into uniform wet granules with less fine powder, oven drying at 40-50 deg.C until the water content of the material is below 3%, grading, making into uniform granules, sieving with 20 mesh sieve, mixing with magnesium stearate, tabletting with tablet press to obtain various tablets with different types, and moisture-proof packaging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010467405.1A CN111567797A (en) | 2020-05-28 | 2020-05-28 | Compound jasmine tea chewable tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010467405.1A CN111567797A (en) | 2020-05-28 | 2020-05-28 | Compound jasmine tea chewable tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111567797A true CN111567797A (en) | 2020-08-25 |
Family
ID=72115822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010467405.1A Pending CN111567797A (en) | 2020-05-28 | 2020-05-28 | Compound jasmine tea chewable tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111567797A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113712201A (en) * | 2021-08-16 | 2021-11-30 | 深圳市萱嘉生物科技有限公司 | Preparation method and application of medicinal and edible composition |
| CN114680328A (en) * | 2022-03-30 | 2022-07-01 | 贵州斛多福食品有限公司 | Preparation method of rhizoma polygonati chewable pills added with dendrobium officinale |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102106497A (en) * | 2010-12-29 | 2011-06-29 | 九三粮油工业集团有限公司 | Compound combined rape pollen chewable tablets and preparation method thereof |
| CN103463458A (en) * | 2013-09-26 | 2013-12-25 | 张娥珍 | Dendrobium candidum compound chewable tablets and preparation method thereof |
| CN104522467A (en) * | 2014-12-22 | 2015-04-22 | 南京师范大学 | Rhizoma polygonati polysaccharide chewable tablet and preparation method thereof |
| CN105614426A (en) * | 2014-10-27 | 2016-06-01 | 卢雨萍 | Jasmine flower chewable tablet and preparation method thereof |
| CN106318637A (en) * | 2016-08-28 | 2017-01-11 | 广西灏源盛世生物科技有限公司 | Method for extracting Arabian jasmine flower essential oil |
| CN106615549A (en) * | 2016-11-17 | 2017-05-10 | 安徽省旌德博仕达农业科技有限公司 | Ginseng sealwort tablet and preparation method thereof |
| CN109730314A (en) * | 2019-03-04 | 2019-05-10 | 宁波易中禾药用植物研究院有限公司 | A kind of processing method of dendrobium nobile composite chewable tablet |
-
2020
- 2020-05-28 CN CN202010467405.1A patent/CN111567797A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102106497A (en) * | 2010-12-29 | 2011-06-29 | 九三粮油工业集团有限公司 | Compound combined rape pollen chewable tablets and preparation method thereof |
| CN103463458A (en) * | 2013-09-26 | 2013-12-25 | 张娥珍 | Dendrobium candidum compound chewable tablets and preparation method thereof |
| CN105614426A (en) * | 2014-10-27 | 2016-06-01 | 卢雨萍 | Jasmine flower chewable tablet and preparation method thereof |
| CN104522467A (en) * | 2014-12-22 | 2015-04-22 | 南京师范大学 | Rhizoma polygonati polysaccharide chewable tablet and preparation method thereof |
| CN106318637A (en) * | 2016-08-28 | 2017-01-11 | 广西灏源盛世生物科技有限公司 | Method for extracting Arabian jasmine flower essential oil |
| CN106615549A (en) * | 2016-11-17 | 2017-05-10 | 安徽省旌德博仕达农业科技有限公司 | Ginseng sealwort tablet and preparation method thereof |
| CN109730314A (en) * | 2019-03-04 | 2019-05-10 | 宁波易中禾药用植物研究院有限公司 | A kind of processing method of dendrobium nobile composite chewable tablet |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113712201A (en) * | 2021-08-16 | 2021-11-30 | 深圳市萱嘉生物科技有限公司 | Preparation method and application of medicinal and edible composition |
| CN114680328A (en) * | 2022-03-30 | 2022-07-01 | 贵州斛多福食品有限公司 | Preparation method of rhizoma polygonati chewable pills added with dendrobium officinale |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104739921B (en) | A kind of prescription lozenge and preparation method thereof for alleviating visual fatigue | |
| CN104799146A (en) | Functional nutritional good composition for improving sub-health and preparation method thereof | |
| US10111451B2 (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
| CN112121144B (en) | Roxburgh rose composition and preparation method and application thereof | |
| CN106035861A (en) | Inonotus obliquus substitutional tea with health-care functions and preparation method thereof | |
| CN113768004A (en) | White tea seasoning tea containing dried orange peel and preparation method thereof | |
| CN111012876A (en) | Product for improving sleep and preparation method and application thereof | |
| CN107853517B (en) | Traditional Chinese medicine beverage capable of refreshing and resisting fatigue and preparation method thereof | |
| CN111567797A (en) | Compound jasmine tea chewable tablet and preparation method thereof | |
| CN102813765A (en) | Method for preparing Zhixinkang preparation | |
| CN109619329A (en) | A kind of Milkvetch root composition and astragalus root beverage prepared therefrom and preparation method thereof | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
| KR20130029284A (en) | Composition of healthy foods for treatment of dementia | |
| CN101254263A (en) | Compound Japanese polygala oral liquid and method of preparing the same | |
| KR100773889B1 (en) | Composition containing effective ingredient of liquefied medical herb extracts for hangover removal and manufacturing method of thereof | |
| CN1142785C (en) | Antifatigue capsule | |
| CN101745042B (en) | Composition with effects of relieving alcoholism and protecting liver and preparation method thereof | |
| CN107712890A (en) | A kind of antitoxic heart-soothing and sedative cream taste and preparation method thereof | |
| CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
| KR20160064057A (en) | Health supplement food containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
| CN107212402B (en) | Blood pressure lowering food and preparation method thereof | |
| CN109170052A (en) | A kind of dendrobium nobile stomach-nourishing health tea and preparation method thereof | |
| CN115607629B (en) | Traditional Chinese medicine composition with liver protecting and alcohol effect dispelling functions and preparation method thereof | |
| CN109106842B (en) | A medicine for stopping smoking and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200825 |
|
| RJ01 | Rejection of invention patent application after publication |